ArticleImmunology letters2020
Are there any association between COVID-19 severity and immunosuppressive therapy?
Article in Immunology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.Scientific reports · 2022Pooled it
- Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.United European gastroenterology journal · 2021Pooled it
- A kaleidoscopic autoimmune syndrome (COVAS) following COVID-19 exposure.Clinical rheumatology · 2026Article
- A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19.medRxiv : the preprint server for health sciences · 2025Article
- Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review.Middle East journal of digestive diseases · 2022Review
- Gastrointestinal and Pancratohepatobiliary Cancers: A Comprehensive Review on Epidemiology and Risk Factors Worldwide.Middle East journal of digestive diseases · 2022Review
- Gastrointestinal manifestations with COVID-19 virus infection: A Moroccan prospective study.Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology · 2021Article
- Gastrointestinal and Liver Manifestations in COVID-19 Population.Middle East journal of digestive diseases · 2021Review
- Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases.Children (Basel, Switzerland) · 2021Review
- IL10RB as a key regulator of COVID-19 host susceptibility and severity.medRxiv : the preprint server for health sciences · 2021Article
- Risk of Severe Covid-19 in Patients with Celiac Disease: A Population-Based Cohort Study.Clinical epidemiology · 2021Article
- Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review.Archives of academic emergency medicine · 2020Review
- Diagnosis of Good Syndrome following Recurrent Coronavirus Disease-2019 Infections.Case reports in oncologyArticle
Corrections and comments
- Comment on
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.